Physician profile
Laura R Lefkowitz
NPI 1619991874
$1,385.59
in general payments reported to CMS, 2019-2025
18 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.71 · 2021: $25.92 · 2022: $287 · 2023: $470 · 2024: $407 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $253.94 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Saxum Surgical, INC. | $183.27 | 2022 | |
| Inari Medical, INC. | $169.59 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Melinta Therapeutics, LLC | $138.25 | 2023 | Kimyrsa |
| Biotissue Holdings INC. | $108.38 | 2023 | |
| Paratek Pharmaceuticals, INC. | $85.97 | 2023-2025 | Nuzyra |
| Polynovo North America LLC | $65.95 | 2025 | Novosorb Btm |
| Bioventus LLC | $51.57 | 2019-2022 | |
| Mimedx Group, INC. | $51.08 | 2025 | |
| Stryker Corporation | $48.05 | 2022 | |
| Avita Medical Americas, LLC | $43.64 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $34.48 | 2025 | |
| Amgen INC. | $29.81 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $29.06 | 2023 | Krystexxa |
| Organogenesis INC. | $25.92 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $24.17 | 2022 | |
| Depuy Synthes Sales INC. | $22.80 | 2024 | |
| Abbott Laboratories | $19.66 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Lefkowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.